Published in Ann Neurol on January 01, 2003
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology (2011) 2.27
Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review. J Neurol Neurosurg Psychiatry (2007) 1.22
Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind. Cortex (2011) 0.95
Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study. Neuroimage Clin (2015) 0.75
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ (2004) 3.29
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2009) 2.76
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
The cognitive profile of posterior cortical atrophy. Neurology (2006) 2.64
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol (2005) 2.36
Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia (2006) 2.27
Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry (2006) 2.10
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve. Neurology (2010) 1.73
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology (2013) 1.70
Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage (2008) 1.62
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ (2008) 1.55
Utility-based Quality of Life measures in Alzheimer's disease. Qual Life Res (2006) 1.55
Self-appraisal in behavioural variant frontotemporal degeneration. J Neurol Neurosurg Psychiatry (2012) 1.49
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol (2003) 1.39
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging (2012) 1.30
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc (2007) 1.28
The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev (2008) 1.25
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.21
The contribution of autobiographical significance to semantic memory: evidence from Alzheimer's disease, semantic dementia, and amnesia. Neuropsychologia (2004) 1.17
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol (2009) 1.17
Neuropsychological testing and assessment for dementia. Alzheimers Dement (2007) 1.15
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol (2004) 1.11
Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 1.09
Exploded drawing in posterior cortical atrophy. Neurology (2006) 1.08
Frontotemporal dementia: a review for primary care physicians. Am Fam Physician (2010) 1.08
The Philadelphia Brief Assessment of Cognition (PBAC): a validated screening measure for dementia. Clin Neuropsychol (2011) 1.06
Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex (2012) 1.01
Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci (2007) 1.00
Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. J Neurol Sci (2006) 0.99
Magnetic resonance imaging in frontotemporal dementia shows subcortical atrophy. Dement Geriatr Cogn Disord (2008) 0.99
The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain (2011) 0.99
Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord (2007) 0.98
Autobiographical memory and patterns of brain atrophy in frontotemporal lobar degeneration. J Cogn Neurosci (2008) 0.97
Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia. Acta Neuropathol (2007) 0.97
Corticobasal degeneration and progressive aphasia. Neurology (2006) 0.96
The prevalence of misidentification syndromes in neurodegenerative diseases. Alzheimer Dis Assoc Disord (2008) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dement Geriatr Cogn Disord (2006) 0.95
Differentiating the frontal variant of Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.94
Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL. Neurology (2007) 0.93
Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals. Am J Geriatr Psychiatry (2007) 0.93
Category and letter fluency in semantic dementia, primary progressive aphasia, and Alzheimer's disease. Brain Lang (2005) 0.92
The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci (2003) 0.92
Learning and memory as a function of age in Down syndrome: a study using animal-based tasks. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.92
Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population. Neuroimage (2013) 0.90
The neural basis for establishing a focal point in pure coordination games. Soc Cogn Affect Neurosci (2011) 0.90
Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. Am J Geriatr Psychiatry (2011) 0.90
Laboratory investigations and treatment in frontotemporal dementia. Ann Neurol (2003) 0.90
Episodic memory and regional atrophy in frontotemporal lobar degeneration. Neuropsychologia (2007) 0.89
Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging (2002) 0.89
Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. J Neurol Sci (2005) 0.89
Frontotemporal dementia and pharmacologic interventions. J Neuropsychiatry Clin Neurosci (2010) 0.88
Differentiating primary progressive aphasias in a brief sample of connected speech. Neurology (2013) 0.87
Quantitative and qualitative analyses of clock drawing in frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc (2006) 0.87
Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. Am J Geriatr Psychiatry (2011) 0.87
Metabolic markers of cobalamin deficiency and cognitive function in normal older adults. J Am Geriatr Soc (2004) 0.87
Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J Gerontol A Biol Sci Med Sci (2004) 0.87
Comparative semantic profiles in semantic dementia and Alzheimer's disease. Brain (2013) 0.87
Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology (2013) 0.86
Is low-dose oral cobalamin enough to normalize cobalamin function in older people? J Am Geriatr Soc (2002) 0.86
Delusions and hallucinations in frontotemporal dementia: a clinicopathologic case report. Cogn Behav Neurol (2008) 0.86
Salience network resting-state activity: prediction of frontotemporal dementia progression. JAMA Neurol (2013) 0.85
Neuropsychological functioning in PLS: a comparison with ALS. Can J Neurol Sci (2011) 0.85
Apathy in dementia: clinical and sociodemographic correlates. J Neuropsychiatry Clin Neurosci (2008) 0.84
Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel. Ann Neurol (2003) 0.84
Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener (2014) 0.84
Early features in frontotemporal dementia. Curr Alzheimer Res (2009) 0.84
Grammatical comprehension deficits in non-fluent/agrammatic primary progressive aphasia. J Neurol Neurosurg Psychiatry (2013) 0.83
Temporally graded semantic memory loss in Alzheimer's disease: cross-sectional and longitudinal studies. Cogn Neuropsychol (2004) 0.83
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatr Dis Treat (2011) 0.83
Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study. J Neurol Sci (2009) 0.83
An exploration of cognitive subgroups in Alzheimer's disease. J Int Neuropsychol Soc (2009) 0.82
Cognitive and behavioural impairment in Parkinson's disease. Int Rev Psychiatry (2008) 0.82
Age-associated cognitive deficits in humans and dogs: a comparative neuropsychological approach. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.82
Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration. Neuropsychologia (2010) 0.81
Action verb comprehension in amyotrophic lateral sclerosis and Parkinson's disease. J Neurol (2014) 0.81
Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord (2008) 0.81
Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort. Dement Geriatr Cogn Disord (2008) 0.81
Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship. Neuropsychol Rev (2011) 0.81
Functional neural correlates of emotional expression processing deficits in behavioural variant frontotemporal dementia. J Psychiatry Neurosci (2013) 0.81
Impaired cognitive flexibility in amyotrophic lateral sclerosis. Cogn Behav Neurol (2015) 0.81
Gerstmann-Sträussler-Scheinker disease with the Q217R mutation mimicking frontotemporal dementia. Acta Neuropathol (2005) 0.80
Cerebral haemodynamic changes accompanying cognitive impairment in primary lateral sclerosis. Amyotroph Lateral Scler (2008) 0.80
Frontotemporal lobar degeneration: clinical and pathologic overview. Handb Clin Neurol (2008) 0.80
Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary. Can J Neurol Sci (2006) 0.79
Cognitive and behavioral changes in the Parkinson-plus syndromes. Adv Neurol (2005) 0.79
Associative (prosop)agnosia without (apparent) perceptual deficits: a case-study. Neuropsychologia (2007) 0.79
Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.79